16th Annual Coastal Dermatology Symposium

October 15 - 16, 2020
Registration Deadline: January 1, 2021
Virtual Platform Close Date: January 14, 2021

CME/CE Credit


Dermatologists • Family Physicians • Internists • Physician Assistants • Nurse Practitioners • Nurses • Residents

Learning Objectives

After completing this live activity, participants should be better able to:

Rosacea, Acne, Contact Dermatitis

  • Design a comprehensive treatment plan for acne, rosacea, and contact dermatitis based on clinical guidelines and incorporating pharmacological and non-pharmacological therapies.

Actinic Keratosis (AKs) vs Warts

  • Identify the similarities in the pathogenesis, histology, and clinical presentations of warts and actinic keratosis in terms of potential targets for therapy.
  • Describe the treatment algorithms currently in practice in the dermatology community and how they can be translated to approaching patients with both conditions.

Autoimmune Skin Diseases

  • Develop a strategy for identifying cutaneous adverse reactions while treating rheumatic skin diseases.
  • Identify potential side effects of medications used to treat rheumatic skin diseases.


  • Identify the diagnostic criteria for focal and general hyperhidrosis.
  • Analyze the mechanisms of action of therapeutic options for hyperhidrosis.


  • Recognize differences between old and new versions of HPV and VZV vaccines
  • Identify novel vaccines recently developed and approved for rare, potentially fatal diseases
  • Advocate for vaccine development for pathogens where it has been lacking


  • Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines.
  • Design treatment strategies that incorporate of biologic therapies in the management of appropriately selected patients with psoriasis.
  • Identify key patient characteristics to individualize treatment selection in patients with psoriasis.

Pediatric Dermatology

  • Describe evolving practices and therapeutics for molluscum in children
  • Discuss the evolution of systemic and new topical therapies for pediatric atopic dermatitis
  • Recognize COVID-associated acral erythema in children and changes in practice related to the epidemic

Atopic Dermatitis

  • Assess disease severity and impact of atopic dermatitis on the patient and family
  • Describe new data on bathing, age indications for non-steroidal medications, and evolving indications and emerging research on topical agents for atopic dermatitis
  • Explain emerging systemic therapies and how they may be utilized for moderate to severe atopic dermatitis

Dermatomyositis and Cutaneous Lupus

  • Distinguish lupus from dermatomyositis on clinical grounds.

The Red Face

  • Categorize patients with a “red face” into four major groups
  • Identify the three-common cause of plethora and know the significance of each
  • Distinguish lupus from dermatomyositis on clinical grounds


  • Discuss photoprotection with patients, including pediatric patients and their caregivers.
  • Describe the algorithm for the diagnosis of photodermatoses.


Accreditation and Designation statements

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 13.25 contact hours.  Pharmacotherapy contact hours for Advanced Practice Nurses will be designated on your certificate.



The self-assessment program offered at the 16th Coastal Dermatology Symposium is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points. Please be sure to report completion of any self-assessment programs on your MOC-D table located in your ABD profile (www.abderm.org).


Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Follow Us

Jointly Provided By